Article
The diagnostic utility of BRAF VE1 mutation-specific immunohistochemistry in ameloblastoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Nov 2022
Mendez Luvy D, Wolsefer Nicholas S, Asa Sylvia L, Wasman Jay, Yoest Jennifer M, Stojanov Ivan J
Abstract excerpt
Ameloblastoma is a benign, locally aggressive odontogenic neoplasm with variable solid and cystic morphology. On account of its histologic variety, diagnostically challenging cases can bear resemblance to odontogenic keratocyst/keratocystic odontogenic tumor (KCOT) or dentigerous cyst (DC). BRAFV600E mutation has been reported to be specific for and frequent in ameloblastoma, and this study evaluated the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
